Substance P induces gastric mucosal protection at supraspinal level via increasing the level of endomorphin-2 in rats

Brain Research Bulletin

Volumn 91, Issue , 2013, Pages 38-45

  Brancati, Serena B ^a   Zádori, Zoltán S ^b   Németh, József ^c   Gyires, Klára ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Calcitonin gene related peptide; Endomorphin; Gastric ulcer; Substance P; Tachykinins

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; ENDOMORPHIN 2; MU OPIATE RECEPTOR ANTAGONIST; NEUROKININ 1 RECEPTOR ANTAGONIST; NEUROKININ 2 RECEPTOR ANTAGONIST; NEUROKININ 3 RECEPTOR ANTAGONIST; NITRIC OXIDE; PROSTAGLANDIN; SOMATOSTATIN; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; STOMACH MOTILITY; STOMACH MUCOSA; STOMACH PROTECTION; STOMACH ULCER;

ALCOHOLS; ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; DISEASE MODELS, ANIMAL; ETHANOL; GASTRIC MUCOSA; INJECTIONS, INTRAVENTRICULAR; MALE; NEUROTRANSMITTER AGENTS; OLIGOPEPTIDES; RADIOIMMUNOASSAY; RATS; RATS, WISTAR; STOMACH ULCER; SUBSTANCE P;

EID: 84873832925     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2013.01.004     Document Type: Article

References (74)

1. Al-Khrasani M., Lackó E., Riba P., Király K., Sobor M., Timár J., Mousa S., Schäfer M., Fürst S. The central versus peripheral antinociceptive effects of μ-opioid receptor agonists in the new model of rat visceral pain. Brain Research Bulletin 2012, 87:238-243.
2. Bailey C.P., Maubach K.A., Jones R.S. Neurokinin-1 receptors in the rat nucleus tractus solitarius: pre- and postsynaptic modulation of glutamate and GABA release. Neuroscience 2004, 127:467-479.
3. Beresford I.J., Sheldrick R.L., Ball D.I., Turpin M.P., Walsh D.M., Hawcock A.B., Coleman R.A., Hagan R.M., Tyers M.B. GR159897, a potent non-peptide antagonist at tachykinin NK2 receptors. European Journal of Pharmacology 1995, 272:241-248.
4. Bunnett N.W., Helton W.S., Debas H.T., Ensinck J.W. CGRP stimulates the release of pro-somatostatin-derived peptides from the gastric fundus. American Journal of Physiology 1990, 258:316-319.
5. Colin I., Blondeau C., Baude A. Neurokinin release in the rat nucleus of the solitary tract via NMDA and AMPA receptors. Neuroscience 2002, 115:1023-1033.
6. Dib B. Food and water intake suppression by intracerebroventricular administration of substance P in food- and water-deprived rats. Brain Research 1999, 830:38-42.
7. Dixon M.K., Nathan N.A., Hornby P.J. Immunocytochemical distribution of neurokinin 1 receptor in rat dorsal vagal complex. Peptides 1998, 19:913-923.
8. Drew G.M., Mitchell V.A., Vaughan C.W. Postsynaptic actions of substance P on rat periaqueductal grey neurons in vitro. Neuropharmacology 2005, 49:587-595.
9. Evangelista S., Lippe I.T., Rovero P., Maggi C.A., Meli A. Tachykinins protect against ethanol-induced gastric lesions in rats. Peptides 1989, 10:79-81.
10. Evangelista S., Tramontana M., Panerai C., Surrenti C., Renzi D. Gastric lesions induced by concentrated ethanol are associated with a decrease in gastric calcitonin gene-related peptide-like immunoreactivity in rats. Scandinavian Journal of Gastroenterology 1993, 28:1112-1114.
11. Ferreira M., Sahibzada N., Shi M., Panico W., Niedringhaus M., Wasserman A., Kellar K.J., Verbalis J., Gillis R.A. CNS site of action and brainstem circuitry responsible for the intravenous effects of nicotine on gastric tone. Journal of Neuroscience 2002, 22:2764-2779.
12. Frederickson R.C., Burgis V., Harrell C.E., Edwards J.D. Dual actions of substance P on nociception: possible role of endogenous opioids. Science 1978, 199:1359-1362.
13. Gazzieri D., Trevisani M., Springer J., Harrison S., Cottrell G.S., Andre E., Nicoletti P., Massi D., Zecchi S., Nosi D., Santucci M., Gerard N.P., Lucattelli M., Lungarella G., Fischer A., Grady E.F., Bunnett N.W., Geppetti P. Substance P released by TRPV1-expressing neurons produces reactive oxygen species that mediate ethanol-induced gastric injury. Free Radical Biology and Medicine 2007, 43:581-589.
14. Greenwell T.N., Martin-Schild S., Inglis F.M., Zadina J.E. Colocalization and shared distribution of endomorphins with substance P, calcitonin gene-related peptide, gamma-aminobutyric acid, and the mu opioid receptor. Journal of Comparative Neurology 2007, 503:319-333.
15. Grijalva C.V., Novin D. The role of the hypothalamus and dorsal vagal complex in gastrointestinal function and pathophysiology. Annals of the New York Academy of Sciences 1990, 597:207-222.
16. Guidobono F., Pagani F., Ticozzi C., Sibilia V., Netti C. Investigation on the mechanisms involved in the central protective effect of amylin on gastric ulcers in rats. British Journal of Pharmacology 1998, 125:23-28.
17. Gyires K. Morphine inhibits the ethanol-induced gastric damage in rats. Archives Internationales de Pharmacodynamie et de Therapie 1990, 306:170-181.
18. Gyires K. Neuropeptides and gastric mucosal homeostasis. Current Topics in Medicinal Chemistry 2004, 4:63-73.
19. Gyires K., Németh J., Zádori Z.S. Gastric mucosal protection and central nervous system. Current Pharmaceutical Design 2013, 19:34-39.
20. Gyires K., Rónai A.Z. Supraspinal delta- and mu-opioid receptors mediate gastric mucosal protection in the rat. Journal of Pharmacology and Experimental Therapeutics 2001, 297:1010-1015.
21. Gyires K., Rónai A.Z., Müllner K., Fürst S. Intracerebroventricular injection of clonidine releases beta-endorphin to induce mucosal protection in the rat. Neuropharmacology 2000, 39:961-968.
22. Haley G.E., Flynn F.W. Tachykinin NK3 receptor contribution to systemic release of vasopressin and oxytocin in response to osmotic and hypotensive challenge. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2007, 293:931-937.
23. Haller J. The neurobiology of abnormal manifestations of aggression-a review of hypothalamic mechanisms in cats, rodents, and humans. Brain Research Bulletin 2012, (Epub ahead of print).
24. Harrison S., Geppetti P., Substance P. International Journal of Biochemistry and Cell Biology 2001, 33:555-576.
25. Hasenöhrl R.U., Jentjens O., Souza Silva M.A., Tomaz C., Huston J.P. Anxiolytic-like action of neurokinin substance P administered systemically or into the nucleus basalis magnocellularis region. European Journal of Pharmacology 1998, 354:123-133.
26. Hernandez D.E., Nemeroff C.B., Orlando R.C., Prange A.J. The effect of centrally administered neuropeptides on the development of stress-induced gastric ulcers in rats. Journal of Neuroscience Research 1983, 9:145-157.
27. Holzer P. Role of visceral afferent neurons in mucosal inflammation and defense. Current Opinion in Pharmacology 2007, 7:563-569.
28. Holzer P., Holzer-Petsche U. Tachykinins in the gut. Part I. Expression, release and motor function. Pharmacology and Therapeutics 1997, 73:173-217.
29. Holzer P., Lippe I.T., Jocic M., Wachter C., Erb R., Heinemann A. Nitric oxide-dependent and -independent hyperaemia due to calcitonin gene-related peptide in the rat stomach. British Journal of Pharmacology 1993, 110:404-410.
30. Improta G., Broccardo M. Tachykinins: effects on gastric secretion and emptying in rats. Pharmacological Research 1990, 22:605-610.
31. 5NKA(4-10), a tachykinin NK2 receptor agonist, in rats. Neuropeptides 1997, 31:399-402.
32. Kaneko H., Mitsuma T., Nagai H., Mori S., Iyo T., Kusugami K., Taché Y. Central action of adrenomedullin to prevent ethanol induced gastric injury through vagal pathways in rats. American Journal of Physiology 1998, 274:1783-1788.
33. Karmeli F., Eliakim R., Okon E., Rachmilewitz D. Gastric mucosal damage by ethanol is mediated by substance P and prevented by ketotifen, a mast cell stabilizer. Gastroenterology 1991, 100:1206-1216.
34. Kato K., Yang H., Taché Y. Role of peripheral capsaicin-sensitive neurons and CGRP in central vagally mediated gastroprotective effect of TRH. American Journal of Physiology 1994, 266:1610-1614.
35. Kemény L.V., Hegyi P., Rakonczay Z., Borka K., Korompay A., Gray M.A., Argent B.E., Venglovecz V. Substance P inhibits pancreatic ductal bicarbonate secretion via neurokinin receptors 2 and 3 in the guinea pig exocrine pancreas. Pancreas 2011, 40:793-795.
36. Kertes E., László K., Berta B., Lénárd L. Effects of substance P microinjections into the globus pallidus and central nucleus of amygdala on passive avoidance learning in rats. Behavioural Brain Research 2009, 198:397-403.
37. Kream R.M., Kato T., Shimonaka H., Marchand J.E., Wurm W.H. Substance P markedly potentiates the antinociceptive effects of morphine sulfate administered at the spinal level. Proceedings of the National Academy of Science 1993, 90:3564-3568.
38. Krowicki Z.K., Hornby P.J. Substance P in the dorsal motor nucleus of the vagus evokes gastric motor inhibition via neurokinin 1 receptor in rat. Journal of Pharmacology and Experimental Therapeutics 2000, 293:214-221.
39. Larsen P.J. Distribution of substance P-immunoreactive elements in the preoptic area and the hypothalamus of the rat. Journal of Comparative Neurology 1992, 316:287-313.
40. G-nitro-l-arginine methyl ester on vagally-induced gastric relaxation in the anaesthetized rat. British Journal of Pharmacology 1992, 105:315-320.
41. Lewis M.W., Travagli R.A. Effects of substance P on identified neurons of the rat dorsal motor nucleus of the vagus. American Journal of Physiology - Gastrointestinal and Liver Physiology 2001, 281:164-172.
42. Mantyh P.W. Neurobiology of substance P and the NK1 receptor. Journal of Clinical Psychiatry 2002, 63(Suppl. 11):6-10.
43. Martin-Schild S., Gerall A.A., Kastin A.J., Zadina J.E. Differential distribution of endomorphin 1- and endomorphin 2-like immunoreactivities in the CNS of the rodent. Journal of Comparative Neurology 1999, 405:450-471.
44. Mazzone S.B., Geraghty D.P. Characterization and regulation of tachykinin receptors in the nucleus tractus solitarius. Clinical and Experimental Pharmacology and Physiology 2000, 27:939-942.
45. Mózsik G., Szabó I.L., Czimmer J. Approaches to gastrointestinal cytoprotection: from isolated cells, via animal experiments to healthy human subjects and patients with different gastrointestinal disorders. Current Pharmaceutical Design 2011, 17:1556-1572.
46. Naranjo J.R., Arnedo A., De Felipe M.C., del Rio J. Antinociceptive and Met-enkephalin releasing effects of tachykinins and substance P fragments. Peptides 1986, 7:419-423.
47. Németh J., Görcs T., Helyes Z., Oroszi G., Kocsy T., Pintér E., Szolcsányi J. Development of a new sensitive CGRP radioimmunoassay for neuropharmacological research. Neurobiology (Bp) 1998, 6:473-475.
48. Németh J., Helyes Z., Görcs T., Gardi J., Pintér E., Szolcsányi J. Development of somatostatin radioimmunoassay for the measurement of plasma and tissue contents of hormone. Acta Physiologica Hungarica 1996, 84:313-315.
49. 125I-labelling and purification of peptide hormones and bovine serum albumin. Journal of Radioanalytical and Nuclear Chemistry 2002, 251:129-133.
50. Pacharinsak C., Khasabov S.G., Beitz A.J., Simone D.A. NK-1 receptors in the rostral ventromedial medulla contribute to hyperalgesia produced by intraplantar injection of capsaicin. Pain 2008, 139:34-46.
51. Pantaleo N., Chadwick W., Park S.S., Wang L., Zhou Y., Martin B., Maudsley S. The mammalian tachykinin ligand-receptor system: an emerging target for central neurological disorders. CNS and Neurological Disorders - Drug Targets 2010, 9:627-635.
52. Parenti C., Arico G., Ronsisvalle G., Scoto G.M. Supraspinal injection of substance P attenuates allodynia and hyperalgesia in a rat model of inflammatory pain. Peptides 2012, 34:412-418.
53. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1986, Academic Press, Inc., San Diego. 2nd ed.
54. Rainsford K.D., Whitehouse M.W. Biochemical gastro-protection from acute ulceration induced by aspirin and related drugs. Biochemical Pharmacology 1980, 29:1281-1289.
55. Rittner H.L., Lux C., Labuz D., Mousa S.A., Schafer M., Stein C., Brack A. Neurokinin-1 receptor antagonists inhibit the recruitment of opioid-containing leukocytes and impair peripheral antinociception. Anesthesiology 2007, 107:1009-1017.
56. Robert A., Nezamis J.E., Lancaster C., Hanchar A.J. Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology 1979, 77:433-443.
57. i mobilisation, cardiovascular and dural extravasation assays. European Journal of Pharmacology 1996, 317:129-135.
58. Shujaa N., Zádori Z.S., Rónai A.Z., Barna I., Mergl Z., Mózes M.M., Gyires K. Analysis of the effect of neuropeptides and cannabinoids in gastric mucosal defense initiated centrally in the rat. Journal of Physiology and Pharmacology 2009, 60(Suppl 7):93-100.
59. Spencer S.E., Talman W.T. Central modulation of gastric pressure by substance P: a comparison with glutamate and acetylcholine. Brain Research 1986, 385:371-374.
60. Stroff T., Plate S., Ebrahim J.S., Ehrlich K.H., Respondek M., Peskar B.M. Tachykinin-induced increase in gastric mucosal resistance: role of primary afferent neurons, CGRP, and NO. American Journal of Physiology 1996, 271:1017-1027.
61. Szabó S., Trier S.J., Frankel P.W. Sulfhydryl compounds may mediate gastric cytoprotection. Science 1981, 214:200-202.
62. Szemenyei E., Barna I., Mergl Z., Keresztes A., Darula Z., Kató E., Tóth G., Rónai A.Z. Detection of a novel immunoreactive endomorphin 2-like peptide in rat brain extracts. Regulatory Peptides 2008, 148:54-61.
63. Taché Y. Brainstem neuropeptides and vagal protection of the gastric mucosal against injury: role of prostaglandins, nitric oxide and calcitonin-gene related peptide in capsaicin afferents. Current Medicinal Chemistry 2012, 19:35-42.
64. Tachibana T., Khan M.S., Matsuda K., Ueda H., Cline M.A. Central administration of substance P inhibits feeding behavior in chicks. Hormones and Behavior 2010, 57:203-208.
65. Takeuchi K., Niida H., Matsumoto J., Ueshima K., Okabe S. Gastric motility changes in capsaicin-induced cytoprotection in the rat stomach. Japanese Journal of Pharmacology 1991, 55:147-155.
66. Takeuchi K., Nishiwaki H., Okabe S. Effects of dopamine on gastric mucosal lesions induced by ethanol in rats. Possible involvement of antigastric motor activity mediated with alpha 2-adrenoceptors. Digestive Diseases and Sciences 1988, 33:1560-1568.
67. Walsh D.M., Stratton S.C., Harvey F.J., Beresford I.J., Hagan R.M. The anxiolytic-like activity of GR159897, a non-peptide NK2 receptor antagonist, in rodent and primate models of anxiety. Psychopharmacology 1995, 121:186-191.
68. Wollemann M., Tóth F., Benyhe S. Protein kinase C inhibitor BIM suspended TRPV1 effect on mu-opioid receptor. Brain Research Bulletin 2013, 90:114-117.
69. Yang H., Kawakubo K., Taché Y. Intracisternal PYY increases gastric mucosal resistance: role of cholinergic, CGRP, and NO pathways. American Journal of Physiology 1999, 277:555-562.
70. Yang H., Taché Y. Substance P in the dorsal vagal complex inhibits medullary TRH-induced gastric acid secretion in rats. American Journal of Physiology 1997, 272:987-993.
71. Yokotani K., Fujiwara M. Effects of substance P on cholinergically stimulated gastric acid secretion and mucosal blood flow in rats. Journal of Pharmacology and Experimental Therapeutics 1985, 232:826-830.
72. Zadina J.E., Hackler L., Ge L.J., Kastin A.J. A potent and selective endogenous agonist for the mu-opiate receptor. Nature 1997, 386:499-502.
73. Zádori Z.S., Shujaa N., Fülöp K., Dunkel P., Gyires K. Pre- and postsynaptic mechanisms in the clonidine- and oxymetazoline-induced inhibition of gastric motility in the rat. Neurochemistry International 2007, 51:297-305.
74. Zádori Z.S., Shujaa N., Köles L., Király K.P., Tekes K., Gyires K. Nocistatin and nociceptin given centrally induce opioid-mediated gastric mucosal protection. Peptides 2008, 29:2257-2265.